InChI=1S/C14H19NO8/c15-4-3-6-1-2-7(17)9(18)13(6)23-14-12(21)11(20)10(19)8(5-16)22-14/h1-3,7-14,16-21H,5H2/b6-3+
Lithospermoside possesses strong inhibitory effects onEpstein-Barr virus early antigen (EBV-EA) activation, the potencies of which were either comparable to or stronger than that of a green tea polyphenol, it also exerts anti-tumor promoting activity in two-stage mouse skin carcinogenesis using 7,12-dimethylbenz[a]anthracene (DMBA) and 12-O-tetradecanoylphorbol-13-acetate (TPA).[1]
Lithospermoside has anti-inflammatory activity.[2]
Lithospermoside has anti-oxidant activity.[3]
English website: Lithospermoside
Japanese website: Lithospermoside
Chinese website: Lithospermoside
[1] Ito H, Miyake M, Nishitani E, et al. Cancer Lett, 1999, 143(1):5-13.
[2] Liu F. Shenyang Pharmaceutical University, 2006.
[3] Zhou R, Xu R, Xiao W, et al. Chinese Journal of Experimental Traditional Medical Formulae, 2015 (15): 116-9.